Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Clinical trial NCT06332950 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06332950
Sponsor: Baohui Han
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2024-04-01
Primary completion: 2027-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.